FDA Cancels Meeting Slated to Select Strains for Next Flu Vaccines

The cancellation followed a postponement of another vaccine meeting.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

U.S. officials have canceled a meeting that was slated to go over the options for the 2025–26 influenza vaccines.

The U.S. Food and Drug Administration (FDA) had been scheduled to meet on March 13 with its vaccine advisers to consider which strains the vaccines should target before the meeting was canceled.